Mikko Hölttä

3.3k total citations · 2 hit papers
21 papers, 2.3k citations indexed

About

Mikko Hölttä is a scholar working on Molecular Biology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Mikko Hölttä has authored 21 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Physiology and 4 papers in Psychiatry and Mental health. Recurrent topics in Mikko Hölttä's work include Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (4 papers) and RNA Interference and Gene Delivery (3 papers). Mikko Hölttä is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (4 papers) and RNA Interference and Gene Delivery (3 papers). Mikko Hölttä collaborates with scholars based in Sweden, United Kingdom and United States. Mikko Hölttä's co-authors include Kaj Blennow, Henrik Zetterberg, Ulf Andréasson, Erik Portelius, Maria Bjerke, Ronald Lautner, Caroline Olsson, Max Petzold, Bob Olsson and Elizabeth Wu and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Mikko Hölttä

20 papers receiving 2.3k citations

Hit Papers

CSF and blood biomarkers for the diagnosis of Alzheimer's... 2016 2026 2019 2022 2016 2019 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
    2016 1.4k citations Bob Olsson, Ronald Lautner et al. The Lancet Neurology profile →
  2. Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells
    2019 316 citations Marco Maugeri, Muhammad Nawaz et al. Nature Communications profile →

Peers

Mikko Hölttä
Juan Manuel Maler Germany
Anja Hviid Simonsen Denmark
Ronald Lautner Sweden
Kina Höglund Sweden
Christoffer Rosén Sweden
Richard Batrla Switzerland
Henrik Zetterberg Sweden
Armand Perret‐Liaudet France
Juan Lantero‐Rodriguez Sweden
Rik van der Kant Netherlands
Juan Manuel Maler Germany
Mikko Hölttä
Citations per year, relative to Mikko Hölttä Mikko Hölttä (= 1×) peers Juan Manuel Maler

Countries citing papers authored by Mikko Hölttä

Since Specialization
Citations

This map shows the geographic impact of Mikko Hölttä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikko Hölttä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikko Hölttä more than expected).

Fields of papers citing papers by Mikko Hölttä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikko Hölttä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikko Hölttä. The network helps show where Mikko Hölttä may publish in the future.

Co-authorship network of co-authors of Mikko Hölttä

This figure shows the co-authorship network connecting the top 25 collaborators of Mikko Hölttä. A scholar is included among the top collaborators of Mikko Hölttä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikko Hölttä. Mikko Hölttä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gennemark, Peter, Nigel Davies, Marie Elebring, et al.. (2023). Injectable Biodegradable Silica Depot for Controlled Subcutaneous Delivery of Antisense Oligonucleotides with beyond Monthly Administration. Molecular Pharmaceutics. 21(1). 143–151.
3.
Weidolf, Lars, Anders Björkbom, Anders Dahlén, et al.. (2021). Distribution and biotransformation of therapeutic antisense oligonucleotides and conjugates. Drug Discovery Today. 26(10). 2244–2258. 20 indexed citations
4.
Sandelius, Åsa, Mikko Hölttä, Stefan Sultana, et al.. (2020). Urinary Kidney Biomarker Panel Detects Preclinical Antisense Oligonucleotide-Induced Tubular Toxicity. Toxicologic Pathology. 48(8). 981–993. 11 indexed citations
5.
6.
Maugeri, Marco, Muhammad Nawaz, Alexandros Papadimitriou, et al.. (2019). Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells. Nature Communications. 10(1). 4333–4333. 316 indexed citations breakdown →
7.
8.
9.
Henderson, Neil, et al.. (2019). Bioanalysis – But Not as we Knew It: An Astrazeneca Perspective of the Last 10 Years Evolution to Meet a Diversifying Portfolio. Bioanalysis. 11(7). 595–599. 2 indexed citations
10.
Sun, Naidi, Bo Ning, Kenny M. Hansson, et al.. (2018). Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing. Scientific Reports. 8(1). 17509–17509. 86 indexed citations
11.
Magdalinou, Nadia, Alastair J. Noyce, Rui Pinto, et al.. (2017). Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics. Parkinsonism & Related Disorders. 37. 65–71. 35 indexed citations
12.
Jeppsson, Anna, Mikko Hölttä, Henrik Zetterberg, et al.. (2016). Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus. Fluids and Barriers of the CNS. 13(1). 13–13. 41 indexed citations
13.
Hölttä, Mikko, Robert A. Dean, Eric Siemers, et al.. (2016). A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans. Alzheimer s Research & Therapy. 8(1). 11–11. 19 indexed citations
14.
Olsson, Bob, Ronald Lautner, Ulf Andréasson, et al.. (2016). CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. The Lancet Neurology. 15(7). 673–684. 1415 indexed citations breakdown →
15.
Portelius, Erik, Mikko Hölttä, Hilkka Soininen, et al.. (2014). Altered Cerebrospinal Fluid Levels of Amyloid β and Amyloid Precursor-Like Protein 1 Peptides in Down’s Syndrome. NeuroMolecular Medicine. 16(2). 510–516. 25 indexed citations
16.
Hölttä, Mikko, Lennart Minthon, Oskar Hansson, et al.. (2014). An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics—Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease. Journal of Proteome Research. 14(2). 654–663. 82 indexed citations
17.
Hölttä, Mikko. (2014). Quantitative neuroproteomics for biomarker discovery in Alzheimer's disease. Gothenburg University Publications Electronic Archive (Gothenburg University). 1 indexed citations
18.
Hölttä, Mikko, Oskar Hansson, Ulf Andréasson, et al.. (2013). Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease. PLoS ONE. 8(6). e66381–e66381. 111 indexed citations
19.
Hölttä, Mikko, Henrik Zetterberg, Ekaterina Mirgorodskaya, et al.. (2012). Peptidome Analysis of Cerebrospinal Fluid by LC-MALDI MS. PLoS ONE. 7(8). e42555–e42555. 51 indexed citations
20.
Portelius, Erik, Mikael K. Gustavsson, Mikko Hölttä, et al.. (2011). Characterization of the Brain β-Amyloid Isoform Pattern at Different Ages of Tg2576 Mice. Neurodegenerative Diseases. 8(5). 352–363. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan Manuel Maler Breakdown of academic impact, for papers by Anja Hviid Simonsen Breakdown of academic impact, for papers by Ronald Lautner Breakdown of academic impact, for papers by Kina Höglund Breakdown of academic impact, for papers by Christoffer Rosén Breakdown of academic impact, for papers by Richard Batrla Breakdown of academic impact, for papers by Henrik Zetterberg Breakdown of academic impact, for papers by Armand Perret‐Liaudet Breakdown of academic impact, for papers by Juan Lantero‐Rodriguez Breakdown of academic impact, for papers by Rik van der Kant
Rankless by CCL
2026